Web20 mag 2015 · Randomized phase III study of etoposide plus cisplatin versus irinotecan plus cisplatin in advanced neuroendocrine carcinoma of the digestive system: A Japan … Webランダム化比較試験(JCOG1213、TOPIC-NEC) 英語 Randomized phase III study of etoposide plus cisplatin combination therapy versus irinotecan plus cisplatin combination therapy in advanced neuroendocrine carcinoma of the digestive system. (JCOG1213,TOPIC-NEC) 試験実施地域/Region;
GI cancer-net 海外学会速報レポート 2024年1月サンフランシス …
Web22 gen 2024 · 日本の78施設で行われた無作為化フェーズ3試験であるjcog1213試験の結果示された。また同試験のサブグループ解析で、膵原発の低分化型神経内分泌細胞 … http://www.jcog.jp/document/s_1213.pdf helloween wikipedia band
「JCOG1213 TOPIC-NEC試験のウラ話」JON-HBP 臨床試験の舞 …
Web20 mag 2015 · The first prospective randomized phase III study comparing EP and IP regimens for GEP-NEC (JCOG 1213 trial, UMIN000014795) is currently being conducted … Web20 dic 2024 · Purpose: To verify the superiority of irinotecan plus cisplatin over etoposide plus cisplatin as postoperative adjuvant chemotherapy for patients with pathologic stage I-IIIA, completely resected, high-grade neuroendocrine carcinoma (HGNEC) of the lung. Methods: This was a randomized, open-label, phase III study on patients with completely … Web研究期間: 2024年01月23日 ~ 2024年08月08日 lakes near hanford ca